SFTPB and lung adenocarcinoma: However, other studies reported that SFTPB is downregulated in lung adenocarcinoma patients with relapse compared to those without relapse [12], and that low expression of surfactant proteins correlates with a lower overall survival rate in lung adenocarcinoma patients with brain metastasis [13].